RETRACTED: Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2

RETRACTED: Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2

Bibliographic Details
Main Authors: Ming-feng Yang, Sheng-yao Sun, Hai-guang Lv, Wei-qi Wang, Han-xia Li, Jing-yi Sun, Zong-yong Zhang
Format: Article
Language:English
Published: American Chemical Society 2023-05-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.3c01296

Internet

https://doi.org/10.1021/acsomega.3c01296

Similar Items